D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 7.51% |
| 3 | Financials | 7.11% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Rocket Pharmaceuticals
RCKT
$340M
| $7.14M | ﹤0.01% |
2,189,750
+1,196,925
| +121% | +$3.77M |
|
1827
Bank of Hawaii
BOH
$3.15B
| $7.13M | ﹤0.01% |
108,582
+28,998
| +36% | +$1.93M |
|
1828
Mettler-Toledo International
MTD
$28.6B
| $7.11M | ﹤0.01% |
5,792
-1,152
| -17% | -$1.44M |
|
|
DMAA
1829
Drugs Made In America Acquisition Corp
DMAA
$260M
| $7.09M | ﹤0.01% |
690,000
| – | – |
|
1830
CALL
American Tower
AMT
$80.8B
| $7.08M | ﹤0.01% |
36,800
+5,200
| +16% | +$1.08M |
|
1831
PUT
Helen of Troy
HELE
$644M
| $7.07M | ﹤0.01% |
280,400
+160,100
| +133% | +$3.88M |
|
1832
Artisan Partners
APAM
$2.79B
| $7.06M | ﹤0.01% |
162,754
+93,724
| +136% | +$4.32M |
|
1833
Aehr Test Systems
AEHR
$2.61B
| $7.06M | ﹤0.01% |
+234,374
| New | +$5.08M |
|
1834
Napco Security Technologies
NSSC
$1.32B
| $7.04M | ﹤0.01% |
163,896
-22,920
| -12% | -$795K |
|
1835
Revolve Group
RVLV
$1.8B
| $7.03M | ﹤0.01% |
329,924
+133,858
| +68% | +$2.92M |
|
1836
PUT
TeraWulf
WULF
$8.75B
| $7.02M | ﹤0.01% |
+615,000
| New | +$4.7M |
|
1837
Royal Gold
RGLD
$16.8B
| $7.02M | ﹤0.01% |
+34,983
| New | +$6.05M |
|
1838
Rocket Companies
RKT
$36.5B
| $7.02M | ﹤0.01% |
362,048
-905,210
| -71% | -$15.8M |
|
1839
Establishment Labs
ESTA
$2.72B
| $7.02M | ﹤0.01% |
171,144
+32,767
| +24% | +$1.34M |
|
|
LWAC
1840
LightWave Acquisition Corp
LWAC
$309M
| $7.01M | ﹤0.01% |
+703,583
| New | +$7.01M |
|
1841
CALL
Hertz
HTZ
$499M
| $7.01M | ﹤0.01% |
1,031,400
+255,000
| +33% | +$1.64M |
|
1842
Telos
TLS
$332M
| $7.01M | ﹤0.01% |
1,024,581
+671,329
| +190% | +$3.21M |
|
1843
CALL
Nutanix
NTNX
$16B
| $6.97M | ﹤0.01% |
93,700
+49,200
| +111% | +$3.61M |
|
|
LKFT
1844
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $6.97M | ﹤0.01% |
201,169
+47,984
| +31% | +$1.53M |
|
1845
Schwab US Dividend Equity ETF
SCHD
$103B
| $6.94M | ﹤0.01% |
254,357
+187,282
| +279% | +$5.11M |
|
|
NML
1846
Neuberger Energy Infrastructure and Income Fund Inc
NML
$593M
| $6.94M | ﹤0.01% |
796,270
| – | – |
|
1847
CALL
Jefferies Financial Group
JEF
$12.6B
| $6.94M | ﹤0.01% |
106,100
+14,500
| +16% | +$884K |
|
1848
Aptiv
APTV
$12B
| $6.93M | ﹤0.01% |
+80,323
| New | +$6.06M |
|
1849
Nomura Holdings
NMR
$28.3B
| $6.91M | ﹤0.01% |
950,836
-111,620
| -11% | -$784K |
|
|
CIVI
1850
PUT
DELISTED
Civitas Resources
CIVI
| $6.91M | ﹤0.01% |
212,600
+106,300
| +100% | +$3.4M |
|
Similar funds
D.E. Shaw & Co's Q3 2025 Portfolio in Review
As of Q3 2025, D.E. Shaw & Co held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co deployed $15.2B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- D.E. Shaw & Co's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- D.E. Shaw & Co added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- D.E. Shaw & Co's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- D.E. Shaw & Co fully exited Hess in Q3 2025, selling an estimated $527M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- D.E. Shaw & Co opened 714 new positions and closed 514 in Q3 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.